Cargando…

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension

Pulmonary vasodilator testing is currently used to guide management of patients with pulmonary arterial hypertension (PAH). However, the utility of the pulmonary vascular response to inhaled nitric oxide (NO) and oxygen in predicting survival has not been established. Eighty patients with WHO Group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malhotra, Rajeev, Hess, Dean, Lewis, Gregory D., Bloch, Kenneth D., Waxman, Aaron B., Semigran, Marc J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183738/ https://www.ncbi.nlm.nih.gov/pubmed/22020367 http://dx.doi.org/10.4103/2045-8932.83449

Ejemplares similares

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022)

Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
por: Ahn, Jee Hwan, et al.
Publicado: (2014)

Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites
por: Nagasaka, Yasuko, et al.
Publicado: (2018)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Xu, Qi-Xia, et al.
Publicado: (2017)

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension
por: Iglarz, Marc, et al.
Publicado: (2015)

Conducted Vasoreactivity: the Dynamical Point of View
por: Postnov, D. E., et al.
Publicado: (2015)

Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance
por: Muela, Henrique Cotchi Simbo, et al.
Publicado: (2017)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
por: Farhat, Nesrine, et al.
Publicado: (2019)

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
por: Araújo, Inês, et al.
Publicado: (2011)

Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine
por: Shafie, Davood, et al.
Publicado: (2015)

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013)

Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary Arteries
por: Grimmer, Benjamin, et al.
Publicado: (2020)

Carotid artery vasoreactivity correlates with abdominal aortic vasoreactivity in young healthy individuals but not in patients with abdominal aortic aneurysm
por: Vermeulen, Jenske J.M., et al.
Publicado: (2022)

Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
por: Signori, Davide, et al.
Publicado: (2022)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension
por: Eljezi, Vedat, et al.
Publicado: (2021)

Cerebral vasoreactivity is not impaired in patients with severe sepsis
por: Szatmári, S, et al.
Publicado: (2011)

Vasoreactivity in CADASIL: Comparison to structural MRI and neuropsychology
por: Moreton, Fiona C, et al.
Publicado: (2017)

Peripheral vasoreactivity in acute ischemic stroke with hemiplegia
por: Wang, Su Jeong, et al.
Publicado: (2021)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

The effects of acute garlic supplementation on the fibrinolytic and vasoreactive response to exercise
por: Womack, C. J., et al.
Publicado: (2015)

Lipopolysaccharide infusion enhances dynamic cerebral autoregulation without affecting cerebral oxygen vasoreactivity in healthy volunteers
por: Berg, Ronan MG, et al.
Publicado: (2013)

An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
por: Liu, Yiwei, et al.
Publicado: (2022)

A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020)

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
por: Hajian, Bita, et al.
Publicado: (2016)

Heterogeneous Cerebral Vasoreactivity Dynamics in Patients with Carotid Stenosis
por: Chang, Ting-Yu, et al.
Publicado: (2013)

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly
por: Zakaria, El Rasheid, et al.
Publicado: (2019)

Acute vasoreactivity test results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease: our experience with 29 cases
por: Asker, Selvi, et al.
Publicado: (2015)

Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019)

Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca(2+) entry via NOX1 and reactive oxygen species
por: Shaifta, Yasin, et al.
Publicado: (2015)

Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension
por: Faria-Urbina, Mariana, et al.
Publicado: (2021)

Inhaled Nitric Oxide Counterbalances ET-1 Dependent Pulmonary Hypertension and Bronchoconstriction in the Pig
por: Clement, M. G., et al.
Publicado: (1994)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling
por: Dumas de la Roque, Eric, et al.
Publicado: (2017)

Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2014)

Author Correction: Peripheral vasoreactivity in acute ischemic stroke with hemiplegia
por: Wang, Su Jeong, et al.
Publicado: (2021)

Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm Lambs
por: Lakshminrusimha, Satyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lefa8m18osj87m1e14lqil7gfd